[In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
Bruno Pradines, Modeste Mabika Mamfoumbi, A Keundjian, Catherine Lebeau, Thierry Fusaı̈, M. Owono Medang, C. Rogier, Daniel Parzy, M Kombila
Abstract
Bruno Pradines, Modeste Mabika Mamfoumbi, A Keundjian, Catherine Lebeau, Thierry Fusaı̈, M. Owono Medang, C. Rogier, Daniel Parzy, M Kombila
Abstract
The in vitro susceptibility of 91 Plasmodium falciparum isolates obtained from malaria-infected children living near Libreville (Gabon) was evaluated against chloroquine and cycloguanil (biologically active metabolite of proguanil), using an isotopic micro-drug susceptibility test. In vitro resistance to chloroquine and cycloguanil was observed in 83% (35/42) and in 38% (30/78) of the patients, respectively. Our data showed that 41% (16/39) of Gabonese field isolates were resistant both to chloroquine and cycloguanil. These findings are of great importance because they might indicate imminent chloroquine-proguanil failure, and there are not many affordable antimalarial drugs to replace chloroquine-proguanil combination.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The in vitro susceptibility of 91 Plasmodium falciparum isolates obtained from malaria-infected children living near Libreville (Gabon) was evaluated against chloroquine and cycloguanil (biologically active metabolite of proguanil), using an isotopic micro-drug susceptibility test. In vitro resistance to chloroquine and cycloguanil was observed in 83% (35/42) and in 38% (30/78) of the patients, respectively. Our data showed that 41% (16/39) of Gabonese field isolates were resistant both to chloroquine and cycloguanil. These findings are of great importance because they might indicate imminent chloroquine-proguanil failure, and there are not many affordable antimalarial drugs to replace chloroquine-proguanil combination.
Key concepts: Proguanil, Chloroquine, Plasmodium falciparum, Malaria, Pharmacology, Quinine, In vitro, Metabolite